NEOADJUVANT TREATMENT
Clinical trials for NEOADJUVANT TREATMENT explained in plain language.
Never miss a new study
Get alerted when new NEOADJUVANT TREATMENT trials appear
Sign up with your email to follow new studies for NEOADJUVANT TREATMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise in shrinking advanced thyroid tumors before surgery
Disease control Recruiting nowThis study tests a drug called zanzalintinib given before surgery to people with advanced thyroid cancer. The goal is to see if the drug can shrink tumors and make surgery more effective. About 45 adults will take part, and researchers will also monitor for side effects.
Matched conditions: NEOADJUVANT TREATMENT
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Promising drug cocktail aims to shrink esophageal tumors before surgery
Disease control Recruiting nowThis study tests whether adding the immunotherapy drug adbelimumab to standard chemotherapy and the targeted drug apatinib can help shrink esophageal cancer before surgery. About 35 adults with resectable stage II–IVA esophageal squamous cell carcinoma will receive this combinati…
Matched conditions: NEOADJUVANT TREATMENT
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Feeding tube before cancer surgery may cut risks
Knowledge-focused Recruiting nowThis study looks at whether giving extra nutrition through a feeding tube (jejunostomy) before surgery can lower the chance of complications after the operation. It involves 670 malnourished patients with esophageal or stomach cancer who are receiving pre-surgery treatment. The g…
Matched conditions: NEOADJUVANT TREATMENT
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated May 17, 2026 09:39 UTC